Covaxin shows 50 percent effectiveness against symptomatic Covid-19 in real-world assessment : Lancet study
Two doses of Covaxin are 50% compelling against symptomatic Covid-19, as indicated by the primary…
Two doses of Covaxin are 50% compelling against symptomatic Covid-19, as indicated by the primary…
The UK will perceive India’s Covaxin punch as an endorsed Covid-19 antibody for inbound travel…
The WHO’s specialized warning gathering will meet on October 26 to consider the crisis use…